About BSV Bioscience Malaysia
BSV Bioscience Malaysia Sdn. Bhd. is a wholly owned subsidiary of Bharat Serums and Vaccines Limited (BSV) (A Mankind Group Company).
Formerly known as Firstline Pharmaceuticals Sdn. Bhd., the Company was incorporated on 9th April, 2003, and subsequently acquired by BSV in 2022.
We are driven by our commitment to innovation and patient care, offering a comprehensive portfolio across Assisted Reproductive Technology (ART), Women’s Health, Men’s Health and Critical Care.
At BSV Malaysia, we work closely with healthcare professionals and strategic partners to deliver trusted, high-quality treatments, while continuing to bolster BSV’s leadership in healthcare access across the country.
About BSV
BSV is a Mankind Group Company. Our mission at BSV is to preserve, protect, and enhance quality of life while we remain committed to ‘Bringing Life to Life’. Our values of Transparency, Agility, Accountability, and Collaboration, hold us in good stead in every step of our patient journey. Numerous pharmaceutical, biotech, and biological products have been developed since the inception of BSV in 1971. We are driven by the goal of improving health and saving lives, through our innovative treatments and cures for patients across the globe. We do this in the critical therapeutic areas of women’s health, critical care, and IUI-IVF.
One of India’s leading biopharmaceutical companies, we keep the patient at the center of all our endeavors, and work towards widening accessibility of our products to reach patients and deliver positive outcomes. Our dedicated Research & Development center in Mumbai, India houses 90+ scientists who work tirelessly in finding new treatments that address unmet medical needs.
Business
BSV has pioneered many firsts
in hard to make pharmaceutical segments.
Therapy Areas
BSV Bioscience Malaysia offers a portfolio supporting reproductive health and fertility care. This includes areas such as infertility, Assisted Reproductive Technology (ART), endometriosis, and hormone-related fertility treatments, alongside nutritional support across pre-pregnancy and pregnancy stages.
Women’s infertility is a major global health concern, often caused by biological, lifestyle, and age-related factors such as irregular ovulation. Early assessment and proactive steps like cycle tracking and healthy habits help to support reproductive health.
Assisted Reproductive Therapy (ART) provides potential pathways to parenthood for couples experiencing challenges in conceiving, through procedures such as IVF and ICSI. These treatments are guided by fertility specialists and are supported with thorough assessments and monitoring. Treatment outcomes vary depending on individual clinical circumstances.
Male infertility is becoming increasingly common and is influenced by biological, lifestyle, or genetic factors. Early awareness and proactive measures are essential, as reproductive health is closely tied to overall wellness.
Patients who are critically ill or immunocompromised, (i. e., those with weakened immune systems) are at increased risk of developing serious infections. The management of life-threatening conditions requires timely and appropriate medical care under the guidance of healthcare professionals.
